Eric Van Cutsem et. al, Phase I/II trial of pimasertib plus gemcitabine in patients with metastatic pancreatic cancer.

//Eric Van Cutsem et. al, Phase I/II trial of pimasertib plus gemcitabine in patients with metastatic pancreatic cancer.

Eric Van Cutsem et. al, Phase I/II trial of pimasertib plus gemcitabine in patients with metastatic pancreatic cancer.

Authors
Products
Request information

Please insert your email address below, we will contact you soon.

I confirm that I have read the information on the personal data management.

I agree to the processing of my personal data
according to the above mentioned information

*Both options must be selected



2018-05-14T15:40:11+00:00